COMMUNIQUÉS West-GlobeNewswire

New Research Demonstrate Biogen’s Continued Commitment to Improve Care of Patients with Multiple Sclerosis Across Treatment Spectrum
12/09/2019
Data highlight benefits of TYSABRI ® (natalizumab) treatment in early multiple sclerosis for achieving NEDA (no evidence of disease activity) and improving disability and cognition An analysis of data from the TYSABRI [...]
Adverum Biotechnologies Reports Positive 24-Week Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD
12/09/2019
-- Zero anti-VEGF rescue injections required after one-time intravitreal dose of ADVM-022 -- -- Sustained improvements in retinal anatomy -- -- Was safe and well tolerated -- -- Data being presented during podium [...]
MedEye Appoints Jort Kooistra as Chief Executive Officer
12/09/2019
MedEye Appoints Jort Kooistra as Chief Executive Officer New CEO to drive international growth of MedEye’s unique medication verification platform Amsterdam, 12 September 2019 - MedEye, an innovative medtech company [...]
Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum
12/09/2019
Pivotal phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at ECTRIMS congress 2019 74% reduction in the risk of relapse for satralizumab [...]
Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy
12/09/2019
Data will be shared with health authorities globally, including the US Food and Drug Administration (FDA) and European Medicines Agency (EMA)Bullet Basel, 12 September 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today [...]
MediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New York
12/09/2019
LA JOLLA, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
11/09/2019
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press release dated August 30 [...]
AuDStandard Announces Partnership With Hearing Tracker
11/09/2019
PEARLAND, Texas, Sept. 11, 2019 (GLOBE NEWSWIRE) -- AuDStandard, The Unbundled Buying Group that provides exclusive pricing, practice growth solutions, detailed analytics and other services to hearing healthcare [...]
MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France
11/09/2019
MOUNTAIN VIEW, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
ERYTECH to Host Second Quarter 2019 Conference Call and Business Update
11/09/2019
LYON, France, Sept. 11, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
ERYTECH tiendra un webcast le 18 septembre 2019 à l’occasion de ses résultats semestriels 2019
11/09/2019
LYON, France, 11 sept. 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans [...]
Apellis Pharmaceuticals Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
11/09/2019
CRESTWOOD, Ky., and WALTHAM, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]
BeiGene Announces Clinical Data to Be Presented at the Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
11/09/2019
BEIJING, China and CAMBRIDGE, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
ObsEva announces new composition of its Executive Committee
11/09/2019
Geneva, Switzerland and Boston, MA – September 11, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11/09/2019
CORAL GABLES, Fla., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) announced today that it has commenced an underwritten public offering of 8.0 million shares of its common stock. [...]
Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting
11/09/2019
BOSTON, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it intends to convene and then adjourn, without conducting any business, its [...]
Novan Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/09/2019
MORRISVILLE, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Compensation Committee of Novan’s Board of Directors granted stock options to purchase [...]
AgraFlora Organics Provides Licensing Guidance and Construction Update Regarding 51,500 Sq./Ft. GMP Edibles Manufacturing Facility
11/09/2019
VANCOUVER, British Columbia, Sept. 11, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA ) ( Frankfurt: PU31 ) ( OTCPK: AGFAF ), a growth oriented and [...]
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/09/2019
BRISBANE, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Pages